# Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

> **NCT00186576** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 40 (estimated)

## Conditions studied

- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Blood and Marrow Transplant (BMT)
- Myelodysplastic Syndromes (MDS)
- Myeloproliferative Disorders (MPD)

## Interventions

- **PROCEDURE:** nonmyeloablative allogeneic hematopoietic cell transplant

## Key facts

- **NCT ID:** NCT00186576
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2004-03
- **Final completion:** 2010-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00186576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00186576, "Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00186576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*